These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 211752)
1. Further investigations on the antioncogenic activity of A/PR8/34 (HON1)- influenza virus on polyoma virus induced tumors in newborn Wistar rats. Desselberger U; Drescher J; Georgii A; Ostertag H Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):411-23. PubMed ID: 211752 [TBL] [Abstract][Full Text] [Related]
2. Antioncogenic activity of influenza virus on polyoma virus induced renal and brain tumors in newborn Wistar rats. Noss G; Stauch G Zentralbl Bakteriol A; 1980 Mar; 246(3):285-93. PubMed ID: 6252720 [TBL] [Abstract][Full Text] [Related]
3. Influence of vaccination with A/PR 8/34 (HO-N1) influenza virus on the oncogenic activity of polyoma virus in newborn Wistar rats. Desselberger U; Drescher J; Georgii A; Ostertag H Cancer Res; 1976 Sep; 36(9 pt.1):3047-50. PubMed ID: 184938 [TBL] [Abstract][Full Text] [Related]
4. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge. Delem A Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269 [TBL] [Abstract][Full Text] [Related]
5. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. Lukacher AE; Wilson CS J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of pp60c-src tyrosyl kinase activity in polyoma virus-infected mouse cells is closely associated with polyoma middle tumor antigen synthesis. Bolen JB; Lewis AM; Israel MA J Cell Biochem; 1985; 27(2):157-67. PubMed ID: 2580850 [TBL] [Abstract][Full Text] [Related]
7. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of the immune response to influenza virus subunit vaccines. Webster RG; Glezen WP; Hannoun C; Laver WG J Immunol; 1977 Dec; 119(6):2073-7. PubMed ID: 915292 [TBL] [Abstract][Full Text] [Related]
9. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Wesley RD; Lager KM Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702 [TBL] [Abstract][Full Text] [Related]
10. [Virus-neutralizing properties of rabbit anti-influenzal IgG with a lowered complement-binding and cytophilic activity]. Tarkhanova IA; Rovnova ZI; Gnevkovskaia TV; Isaeva EI; Kul'berg AIa Biull Eksp Biol Med; 1977 Aug; 84(8):188-91. PubMed ID: 907822 [TBL] [Abstract][Full Text] [Related]
11. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. Marshall D; Sealy R; Sangster M; Coleclough C J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164 [TBL] [Abstract][Full Text] [Related]
12. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased. Heidari S; Berke Z; Berglöf A; Woldegiorgis A; Smith CI; Dalianis T In Vivo; 1999; 13(6):439-44. PubMed ID: 10757034 [TBL] [Abstract][Full Text] [Related]
14. Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test. Ramqvist T; Dalianis T; Reinholdsson G; Klein G; Szigeti R Cancer Res; 1986 Oct; 46(10):5045-8. PubMed ID: 3019520 [TBL] [Abstract][Full Text] [Related]
16. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633 [TBL] [Abstract][Full Text] [Related]